ConductScience.org, home

Paper8093894

Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.

Teppler H and 5 others. J Exp Med, 1993. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. Papers, record 8093894. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8093894

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.
PubMed
Journal
J Exp Med
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2019-05-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Teppler HH
2Kaplan GG
3Smith KAK A
4Montana ALA L
5Meyn PP
6Cohn ZAZ A

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
Interleukin-2Major topic
Adult
CD4-Positive T-Lymphocytes
Dose-Response Relationship, Drug
Evaluation Studies as Topic
Female
Humans
Hypersensitivity, Delayed
Immunity, Cellular
Leukocyte Count
Lymphocyte Activation
Male
Middle Aged
Polyethylene Glycols

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-24775NIAID NIH HHSUnited StatesP01AI024775PubMed and NIHNIH RePORTER
MO1-RR-00102NCRR NIH HHSUnited StatesM01RR000102PubMed and NIHNIH RePORTER

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16176669Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.J Exp Med1982https://conductscience.org/library/papers/6176669PubMed
26403867Structure and expression of a cloned cDNA for human interleukin-2.Nature1983https://conductscience.org/library/papers/6403867PubMed
36308051Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.J Clin Invest1983https://conductscience.org/library/papers/6308051PubMed
46606643Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2.J Clin Immunol1983https://conductscience.org/library/papers/6606643PubMed
56334135Systemic administration of interleukin-2 in humans.J Biol Response Mod1984https://conductscience.org/library/papers/6334135PubMed
66334136Treatment of immunodeficiency with interleukin-2: initial exploration.J Biol Response Mod1984https://conductscience.org/library/papers/6334136PubMed
76334138Use of interleukin-2 in patients with acquired immunodeficiency syndrome.J Biol Response Mod1984https://conductscience.org/library/papers/6334138PubMed
83871344Preliminary clinical observations with recombinant interleukin-2 in patients with AIDS or LAS.Blut1985https://conductscience.org/library/papers/3871344PubMed
93918102Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.J Immunol1985https://conductscience.org/library/papers/3918102PubMed
102582258Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.N Engl J Med1985https://conductscience.org/library/papers/2582258PubMed
112996404Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome.Ann Intern Med1985https://conductscience.org/library/papers/2996404PubMed
122997299Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome.J Clin Invest1985https://conductscience.org/library/papers/2997299PubMed
132940258
Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC).
J Clin Immunol1986https://conductscience.org/library/papers/2940258PubMed
143488345
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
J Immunol1986https://conductscience.org/library/papers/3488345PubMed
153035213Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.J Virol1987https://conductscience.org/library/papers/3035213PubMed
163299089The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.N Engl J Med1987https://conductscience.org/library/papers/3299089PubMed
173113462Therapy of acquired immune deficiency syndrome with recombinant interleukin-2.AIDS Res Hum Retroviruses1987https://conductscience.org/library/papers/3113462PubMed
183126959Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.Br Med J (Clin Res Ed)1988https://conductscience.org/library/papers/3126959PubMed
193131876Interleukin-2: inception, impact, and implications.Science1988https://conductscience.org/library/papers/3131876PubMed
202492110Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2492110PubMed

See all 32 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
30024982Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.PLoS One2018https://conductscience.org/library/papers/30024982PubMed
22797827Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.Nat Mater2012https://conductscience.org/library/papers/22797827PubMed
21849500An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.J Biol Chem2011https://conductscience.org/library/papers/21849500PubMed
10799574Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection.J Virol2000https://conductscience.org/library/papers/10799574PubMed
10647974A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection.Drug Saf2000https://conductscience.org/library/papers/10647974PubMed
10540163Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy.Clin Exp Immunol1999https://conductscience.org/library/papers/10540163PubMed
10535609Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2.J Clin Immunol1999https://conductscience.org/library/papers/10535609PubMed
10337025Treatment of idiopathic CD4 T lymphocytopenia with IL-2.Clin Exp Immunol1999https://conductscience.org/library/papers/10337025PubMed
9616369Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart.Immunology1998https://conductscience.org/library/papers/9616369PubMed
9596772Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.Infect Immun1998https://conductscience.org/library/papers/9596772PubMed
9389737Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.J Clin Invest1997https://conductscience.org/library/papers/9389737PubMed
9089950Immune dysregulation and CD4+ T cell loss in HIV-1 infection.Springer Semin Immunopathol1997https://conductscience.org/library/papers/9089950PubMed
9032357Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2.J Virol1997https://conductscience.org/library/papers/9032357PubMed
8739561Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement.Immunol Res1996https://conductscience.org/library/papers/8739561PubMed
8636433Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors.J Clin Invest1996https://conductscience.org/library/papers/8636433PubMed
8270858Zanvil Alexander Cohn 1926-1993.J Exp Med1994https://conductscience.org/library/papers/8270858PubMed
7955769Effects of route and formulation on clinical pharmacokinetics of interleukin-2.Clin Pharmacokinet1994https://conductscience.org/library/papers/7955769PubMed
7693434Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.Drugs1993https://conductscience.org/library/papers/7693434PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8093894

GET https://conductscience.org/api/papers/v1/8093894/references?page=2